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Yarrowia lipolyticaMitochondrial complex I (proton pumping NADH:ubiquinone oxidoreductase) is the largest and most com-
plicated component of the respiratory electron transfer chain. Despite its central role in biological energy
conversion the structure and function of this membrane integral multiprotein complex is still poorly under-
stood. Recent insights into the structure of complex I by X-ray crystallography have shown that iron–sulfur
cluster N2, the immediate electron donor for ubiquinone, resides about 30 Å above the membrane domain
and mutagenesis studies suggested that the active site for the hydrophobic substrate is located next to this
redox-center. To trace the path for the hydrophobic tail of ubiquinone when it enters the peripheral arm of
complex I, we performed an extensive structure/function analysis of complex I from Yarrowia lipolyticamon-
itoring the interaction of site-directed mutants with ﬁve ubiquinone derivatives carrying different tails. The
catalytic activity of a subset of mutants was strictly dependent on the presence of intact isoprenoid moieties
in the tail. Overall a consistent picture emerged suggesting that the tail of ubiquinone enters through a
narrow path at the interface between the 49-kDa and PSST subunits. Most notably we identiﬁed a set of
methionines that seems to form a hydrophobic gate to the active site reminiscent to the M-domains involved
in the interaction with hydrophobic targeting sequences with the signal recognition particle of the endoplas-
mic reticulum. Interestingly, two of the amino acids critical for the interaction with the ubiquinone tail are
different in bovine complex I and we could show that one of these exchanges is responsible for the lower
sensitivity of Y. lipolytica complex I towards the inhibitor rotenone. This article is part of a Special Issue
entitled: 17th European Bioenergetics Conference (EBEC 2012).
© 2012 Elsevier B.V. All rights reserved.1. Introduction
NADH:ubiquinone oxidoreductase (complex I, EC 1.6.5.3) is the
largest membrane protein complex found in the respiratory chain of
many bacteria andmitochondria [1–3]. It plays a central role in oxida-
tive phosphorylation by transferring electrons from NADH to ubiqui-
none and converting the redox energy of this reaction into an
electrochemical proton gradient that drives ATP synthase. In recent
years an increasing amount of structural information from X-raycyl-4-quinazolinylamine; FMN,
-chloride; NADH, nicotinamide
1S, ubiquinone-1with saturated
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l rights reserved.crystallography studies of bacterial [4–6] and mitochondrial [7] com-
plex I has emerged. Nevertheless, complex I still remains the least un-
derstood component of the respiratory chain by far. Complex I
consists of three functional modules: the N (NADH oxidation) mod-
ule, the Q (ubiquinone reduction) module and the P (proton pump-
ing) module [8]. Prokaryotic complex I comprises the 14 central
subunits with a molecular mass of some 550 kDa representing the
minimal form that harbours the bioenergetic core functions [9,10].
The more than 40 subunits of mitochondrial complex I e.g. from Bos
taurus or from the obligate aerobic yeast Yarrowia lipolytica have a
molecular mass of almost 1 MDa [11–13]. The membrane arm of L-
shaped eukaryotic complex I is embedded in the inner mitochondrial
membrane and the peripheral arm protrudes orthogonally into the
mitochondrial matrix space ([14]; Fig. 1). The peripheral arm har-
bours all redox-active cofactors, one FMN molecule and eight canon-
ical iron–sulfur clusters [15] and the active sites for both substrates
NADH and ubiquinone.
The ubiquinone-reducing catalytic core resides at the interface of
the 49-kDa and PSST subunits [16]. X-ray crystallographic data show
that the electron-donating iron–sulfur cluster N2 is located 25–30 Å
Fig. 1. Position of the ubiquinone reducing site within a structural model of complex I.The overall architecture of the central domains of complex I is illustrated based on X-ray struc-
tural data [7]. The PSST (blue) and 49-kDa (green) subunits, forming the ubiquinone binding cavity of complex I, are shown in surface and cartoon representation. Red, residue Y144
of the 49-kDa subunit in space ﬁll representation marking the binding site of the ubiquinone head group; orange/yellow, iron–sulfur clusters in space ﬁll representation; grey sticks,
FMN; pink, part of the transmission helix connecting the proximal and distal module of the membrane arm [7]; grey lines, approximate position of the membrane; MS, matrix
space; IMS, intermembrane space.
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the ubiquinone head group has to move into a deep binding pocket
within the peripheral arm to reach its electron donor [17]. Functional
characterization of site-directed mutations suggested that the con-
served Y144 of the 49-kDa subunit that resides only 6–8 Å away from
cluster N2 is a key amino acid residue of the ubiquinone binding site
[18,19]: replacing this tyrosine with phenylalanine results in almost
complete loss of catalytic activity when n-decyl-ubiquinone (DBQ)
is used as a substrate. In contrast, with ubiquinone-1 (Q1) and
ubiquinone-2 (Q2) that carry short isoprenoid substituents, electron
transfer and proton pumping activities are normal, although with a
marked increase in apparent KM values. These data indicate that a hy-
drogen bond between the phenolic OH-group of the tyrosine and one
of the ubiquinone head group carbonyls represents the dominant bind-
ing interaction and that at elevated substrate concentrations an iso-
prenoid tail, but not an aliphatic tail can contribute sufﬁcient afﬁnity
to maintain productive substrate binding. Here we further probed this
hypothesis and applied mutagenesis based structure/function analysis
together with systematically modiﬁed substrates synthesized by chem-
ical means, tomap the corresponding binding interactionswith the ﬁrst
two isoprene units of ubiquinone to trace its tail within the active site of
complex I.
2. Materials and methods
2.1. Synthesis of ubiquinone derivatives ubiquinone-1 with saturated side
chain (Q1S) and ubiquinone-2 with saturated side chain (Q2S)
The synthesis of the substrate-analogues Q1S and Q2S starts from
the same precursor coenzyme Q0, which was prepared according to
a published procedure in large scale [20]. The alkyl-chains were intro-
duced by a radical Hunsdiecker decarboxylation of the corresponding
acid using silver nitrate and peroxydisulfate in an acetonitrile/water
mixture, a powerful method to modify the quinone-scaffold [21–23].For Q1S, 4-methylvaleric acid (1) was coupled to Q0 under
Hunsdiecker decarboxylation conditions. Interestingly, based on the
NMR spectrum of the isolated material, only Q1S was formed as the
single desired isomer among three possible isomers. This ﬁnding indi-
cated that the Michael-addition of the alkyl radical to the quinone is
kinetically much faster compared to the rearrangement of the alkyl
radical by hydrogen abstraction to form the other, more thermody-
namically stable isomers 1 and 2 (Scheme 1).
1 g (5.4 mmol) Q0, 0.76 g (6.6 mmol, 1.2 eq.) 4-methylvaleric acid
and 0.25 g silver nitrate were dissolved in 20 ml acetonitrile/water
1:1 mixture under argon atmosphere. To this mixture, a solution of
2.8 g (12.2 mmol) ammonium persulfate dissolved in 15 ml water
was added dropwise. The mixture was heated to 80 °C for 2 h and
stirred at room temperature for 24 h in dark. After extraction of the
crude product with ethylacetate and successive washing of the organic
phase with saturated NaHCO3 the crude product Q1S was puriﬁed by
column chromatography with hexane/ethylacetate 4:1 (Rf=0.48) to
give 320 mg product (24% yield).
1H-NMR (300 MHz, CDCl3): δ[ppm]=3.92 (s, 6 H, 2×OMe), 2.40–
2.34 (t, 3 J=9.0 Hz, 2 H, CH2), 1.93 (s, 3 H, CH3), 1.58–1.49 (m, 1 H,
CH), 1.21–1.13 (m, 2 H, CH2CH), 0.88 (s, 3 H, CHCH3), 0.86 (s, 3 H,
CHCH3).
13C-NMR (75.4 MHz, CDCl3): δ[ppm]=184.6 ; 184.05 (C=O), 144.3;
144.2; 143.3; 138.4 (C), 28.4 (CH), 37.6; 24.3 (CH2), 61.1; 61.08; 22.2;
22.2; 11.7 (CH3).
For Q2S the same procedure was applied. The carboxylic acid (4)
needed for the Hunsdiecker decarboxylation is not commercially
available and was synthesized in three synthetic steps, starting from
commercially available alkyl-bromine (2). Kolbe nitrile synthesis
[24] formed nitrile (3) in good yield, which was subsequently hydro-
lyzed to afford the desired carboxylic acid (4).
Unfortunately, no conversion was observed when carboxylic acid
(4) was used and only the starting materials were recovered. The syn-
thesis plan was changed and Q2S was prepared independently by
Scheme 1. Formation of Q1S as the single isomer under Hunsdiecker decarboxylation condition: a) AgNO3, MeCN/H2O, (NH4)2S2O8, 80 °C.
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(Schemes 2 and 3).
4,8-Dimethylnonanenitrile (3) was prepared from the correspond-
ing bromo compound (2) via Kolbe nitrile synthesis. NaCN (3 g,
58.7 mmol) was heated at 120 °C for 5–10 minutes. The temperature
was set to 90 °C and 25ml DMSO was added. To this mixture, 10 g
(9.4 ml, 45 mmol) 1-bromo-3,7-dimethyloctane (2)was added, forming
a white precipitate immediately. Themixture was heated at 90 °C over-
night. The solvent was removed and the crude product redissolved in
dichloromethane and washed with brine and aqueous saturated
NaHCO3. The organic phase was dried and concentrated to give 7 g
(93% yield) of the pure nitrile as colourless oil.
1H-NMR (300 MHz, CDCl3): δ[ppm]=2.28–2.21 (m, 2 H, C-CH2),
1.67–1.29 (m, 4 H, CH2, 2×CH) 1.21–0.96 (m, 6 H, 3×CH2), 0.83 (d, 3
J=5 Hz, 3 H, CHCH3), 0.79 (d, 3 J=5 Hz, 6 H, CH(CH3)2).
13C-NMR (75.4 MHz, CDCl3): δ[ppm]=119.9 (CN), 32.0; 27.9
(CH), 39.1; 36.4; 32.3; 24.5; 14.9 (CH2), 22.6; 22.5; 18.8 (CH3).
C11H21N (167.17): calcd. C 78.97, H 12.65, N 8.37; found C 78.74, H
12.4 N 8.32.
A mixture of 4,8-dimethylnonanenitrile (3), (4.22 g; 25.2 mmol),
ethanol (25 ml), and an aqueous NaOH/KOH (10 g NaOH, 11 g KOH
in 100 ml of H2O) was stirred at 150 °C. After one day the solutions
turned yellow. The mixture was kept for another day at 150 °C.
The mixture was concentrated under vacuum and the residue was
quenched with water. The aqueous solution was then extracted with
ether to remove the neutral impurities. The aqueous layer was acidi-
ﬁed with conc. HCl (aq.) to pH=1 and extracted with ether. The or-
ganic phase was dried and evaporate to give 3.25 g (70% yield) pure
4,8-dimethylnonanoic acid (4).
1H-NMR (300 MHz, CDCl3): δ[ppm]=11.71 (s br, 1 H,CO2H), 2.35–
2.28 (m, 2 H, CCH2), 1.66–1.57 (m, 1 H, CH) 1.50–1.30 (m, 3 H, 1×CH,
2×CH2) 1.26–1.03 (m, 6 H, 3×CH2), 0.82 (s, 3 H, CH3), 0.80 (s, 3 H,
CH3), 0.79 (s, 3 H, CH3).
13C-NMR (75.4 MHz, CDCl3): δ[ppm]=180.9 (C=O), 36.8; 27.9
(CH), 39.2; 32.3; 31.9; 31.6; 24.6 (CH2), 22.6; 22.5; 19.2 (CH3).
C11H22O2 (186.16): calcd. C 70.92, H 11.9; found C 71.01, H 11.95.
Q2S was prepared by reduction of Q2 in presence of palladium cata-
lyst under a hydrogen atmosphere. 20 mg of Q2 was dissolved in 5 ml
95% ethanol and one drop acetic acid was added with 4 mg of 10% Pd-
C. The mixture was degassed three times and set under H2 atmosphere
and stirred at room temperature overnight. The mixture was ﬁltered
and the solvent removed under vacuum to give Q2S in quantitative
yield.
1H-NMR (300 MHz, CDCl3): δ[ppm]=3.92 (s, 6 H, 2×OMe), 2.45–
2.29 (m, 2 H, CH2), 1.94 (s, 3 H, CH3), 1.54–1.34 (m, 2 H, 2×CH),
1.32–1.11 (m, 8 H, 4×CH2), 0.85 (d, 3J=7.5 Hz, 3 H, CHCH3), 0.78
(d, 3J=7.5 Hz, 6 H, CH(CH3)2).Scheme 2. Synthesis of carboxylic acid (4); a) NaCN, DM13C-NMR (75.4 MHz, CDCl3): δ[ppm]=184.7 ; 184.1 (C=O), 144.3;
143.5; 143.5; 138.4 (C), 33.2; 27.9 (CH), 39.2; 36.8; 35.7; 24.6; 19.4
(CH2), 61.2; 61.2; 24.0; 22.6; 22.6; 11.7 (CH3).
2.2. Mutagenesis and preparation of mitochondrial membranes
All molecular biological procedures were performed according to
[17]. Y. lipolytica deletion strain nukmΔ lacking the NUKM gene, which
encodes the PSST subunit, were complemented with plasmid pUB4 car-
rying site-directedmutant copies of the genomic NUKM gene under the
control of its natural promoter. All point mutations were generated in
Escherichia coli by PCR mutagenesis. After transformation into Y. lipoly-
tica strain nukmΔ and plasmid recovery the correct introduction of
point mutations was conﬁrmed by Sanger sequencing. Mitochondrial
membranes were isolated, homogenized, shock-frozen, and stored at
-80 °C. Mitochondrial membranes from bovine heart were prepared as
described in [25].
2.3. Complex I content and catalytic activities
All kinetic measurements were performed according to [17]. The
content of assembled complex I in the mitochondrial membranes was
assessed by BN-PAGE [26] and by NADH:hexaammineruthenium
(HAR) oxidoreductase activity that was measured as NADH oxidation
(ε340–400 nm=6.22 mM−1 cm−1) in a Molecular Devices SPECTRAmax
PLUS384 plate reader spectrometer at 30 °C in 20 mM Na+/Hepes, pH
8.0, 250 mM sucrose, 2 mM NaN3, 0.2 mM EDTA, 0.2 mM NADH, and
2 mMHAR. The reaction was initiated by the addition of mitochondrial
membranes to a ﬁnal protein concentration of 25 μg/ml.
dNADH:ubiquinone oxidoreductase activity was measured as
dNADH oxidation sensitive to the complex I inhibitor DQA (2-decyl-
4-quinazolinylamine, 27 μM) in the presence of the respective ubiqui-
none derivative as electron acceptor in 20 mM Na+/Mops, pH 7.4,
50 mM NaCl, 2 mM KCN. The reaction was initiated by the addition
of mitochondrial membranes to a ﬁnal protein concentration of
50 μg/ml.
The concentrations of the ubiquinone derivatives were determined
in ethanol with the following extinction coefﬁcients: ε278nm(DBQ)=
14.0 mM−1 cm−1, ε275nm(Q1)=13.7 mM−1 cm−1, ε275nm(Q2)=
13.7 mM−1 cm−1 [27]; for Q1S and Q2S the extinction coefﬁcient of
DBQ was used. For standard activity measurements the different ubi-
quinone derivatives were used at the following concentrations; DBQ
(100 μM), Q1 (200 μM) and Q2 (135 μM), Q1S (150 μM) and Q2S
(130 μM). The reaction was started by adding dNADH supplemented
mitochondrial membranes to measurement buffer containing ubiqui-
none. The inhibitor-sensitive fraction of the ubiquinone reductaseSO; b) i) NaOH, EtOH/H2O, 80 °C, ii) conc. HCl (aq.).
Scheme 3. Synthesis of Q2S. a) (4), AgNO3, MeCN/H2O, (NH4)2S2O8, 80 °C. b) EtOH, 10%
Pd–C, H2.
Fig. 2. Structures of ubiquinone derivatives.DBQ, n-decyl-ubiquinone, Q1, ubiquinone-1,
Q1S, Q1 with saturated side chain, Q2, ubiquinone-2, Q2S, Q2 with saturated side chain.
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of inhibitors. For Vmax, apparent KM and apparent IC50 value determina-
tion by direct numerical ﬁt, appropriate dilution series of the ubiqui-
none derivatives and the inhibitors DQA and rotenone were applied.
Kinetic data (Vmax and KM values) and half maximal inhibitory con-
centrations (IC50) of DQA or rotenonewere determined using essential-
ly the same protocol as described above for the dNADH:ubquinone
oxidoreductase activity assays except that the ubiquinone derivative
or inhibitor concentrations were varied. Vmax and apparent KM values
were obtained by performing numerical ﬁts to the average activity
values (n=3) of eight different ubiquinone derivative concentrations
(0–250 μM, each after subtracting the rate in the presence of DQA)
using the program “Enzﬁtter” (version 2.0.17.0, Biosoft 1999, Cambridge,
UK) with default Michaelis–Menten or IC50 equation parameters. The
curveswereﬁtted using theMarquardt–Levenberg algorithmwith simple
weighting. The standard errors of the kinetic values as calculated by the
program are indicated in the tables and ﬁgures.
2.4. Structural imaging
Structural illustrations of complex I were made by combining X-ray
structural data of complex I from Y. lipolytica [7] with the X-ray structure
of the peripheral arm of complex I from Thermus thermophilus (PDB ID:
2FUG) and using the software package Pymol [28]. If necessary, non-
identical amino acid residues were exchanged in the T. thermophilus
structure using the Pymol mutagenesis wizard to match the Y. lipolytica
sequences.
3. Results
3.1. Characterization of ubiquinone derivatives
To assess the signiﬁcance of the double bonds of the ﬁrst isopren-
oid groups of ubiquinone, we synthesized the variants of Q1 and Q2
with saturated tails, Q1S and Q2S respectively. Lacking the double
bonds in their tails, these substrate-analogues are expected to have
similar electrochemical properties, as compared to their natural sub-
strate counterparts [29], but differ structurally. Synthesis of Q2S and
its catalytic properties with bovine heart complex I have been
reported previously [30]. For all ﬁve substrates (Fig. 2) we deter-
mined NADH:ubiquinone oxidoreductase activities in Y. lipolytica
membranes from the plasmid complemented deletion strains of the
49-kDa and PSST subunits (Table 1). The Michaelis–Menten parame-
ters were similar in all cases with a trend that the derivatives with
isoprenoid side chains gave lower Vmax values, when compared di-
rectly to their saturated counterparts. This is also true for the appar-
ent KM values suggesting a contribution of the double bonds to
substrate binding. The higher apparent KM values for Q1 and Q1S
with the shorter tail can be explained in part also by their lower hy-
drophobicity. Note also that Q2S that only differs from DBQ in that
its decyl-sidechain is branched gave a somewhat higher apparent
KM, but almost the same Vmax, while for Q2 we observed signiﬁcantly
lower maximal rates and a slightly lower apparent KM than for DBQ.
Since, due to its two double bonds, Q2 is more hydrophilic, the kinetic
parameters observed with Q2 indicate a somewhat higher afﬁnity forthe derivative with a tail of two isoprenoid groups. Again, this sug-
gests a speciﬁc role of these groups in substrate binding.
3.2. Amino acid exchanges in the 49-kDa subunit
In a previous study we found that replacing a number of residues
in the 49-kDa subunit by mutagenesis signiﬁcantly affected the inhib-
itor sensitive ubiquinone reductase activity of complex I [17] thereby
deﬁning the binding pocket and access path to cluster N2 for ubiqui-
none. However, at the time we had used only DBQ as a substrate.
Thus, we now re-examined the catalytic activities for 15 of these pre-
viously characterized mutations plus one additional amino acid ex-
change ([16,17,31,32]; Table 2) with the four additional short chain
ubiquinone derivatives available, to further explore the interactions
of the isoprenoid side chain of ubiquinone with complex I.
For most of the amino acid exchanges reported earlier to result in
very low inhibitor sensitive dNADH:DBQ oxidoreductase activities
(H91A, A94I, H95A, V97W, L98F, R99T, V145F, and M188Y) also the
other ubiquinone derivatives were found to be very poor substrates
(Table 2). Only with Q2 low yet discernible rates were observed for
most of these mutations that however never accounted for more
than about 20% of wild-type activity; in mutant V97W we also
found some activity with Q1S. Mutants S146V and M188L with almost
wild-type, and H226A with an intermediate DBQ reductase activity
exhibited similar rates with all ﬁve substrates (Table 2). Five amino
acid exchanges resulted in a characteristic correlation pattern be-
tween catalytic activity and chemical structure of the ubiquinone
tail (Fig. 3A). Mutants S192I and V460A that gave no or very low ac-
tivity with DBQ exhibited signiﬁcant rates for the substrates with an
isoprenoid side chain reaching near wild-type levels for Q2 in case
of S192I. The rates were much lower with Q1S and Q2S, indicating
that activity in these mutants depended largely on the presence of
the double bonds in the ubiquinone tail. Remarkably, for mutants
M195F and F207W that exhibited moderately reduced activities
with DBQ the rates with Q1 and Q2 were signiﬁcantly higher than
those of the wild-type enzyme with the same substrates. Again, this
effect was not observed with the saturated side chains of Q1S and
Q2S. Also amino acid exchange F203W that had hardly any effect on
the DBQ reductase activity exhibited above wild-type rates with Q1
and Q2, but in this case the presence of double bonds seemed less
critical.
To better understand the role of the ubiquinone side-chain, we
went on to determine the Michaelis–Menten parameters for some
of the mutants that showed the most characteristic effects (Table 1).
Table 1
Michaelis–Menten parameters for the ubiquinone derivatives in mitochondrial membranes from plasmid complemented Y. lipolytica deletion strains of the 49-kDa (49-kDa paren-
tal) and PSST (PSST parental) subunits and from selected mutants.
DBQ Q1 Q1S Q2 Q2S
Vmaxa app. KM Vmax app. KM Vmax app. KM Vmax app. KM Vmax app. KM
μmol min−1 CI−1 μM μmol min−1 CI−1 μM μmol min−1 CI−1 μM μmol min−1 CI−1 μM μmol min−1 CI−1 μM
49-kDa parental 0.46±0.02 16±4 0.32±0.01 29±3 0.32±0.01 39±4 0.23±0.02 12±4 0.40±0.02 19±4
S192I n.d. n.d. 0.12±0.03 243±114 n.d. n.d. 0.22±0.01 25±6 0.06±0.01 33±12
M195F 0.21±0.01 16±5 0.20±0.02 40±10 0.17±0.01 44±11 0.22±0.01 13±3 0.13±0.01 16±5
F207W 0.10±0.01 9±3 0.26±0.03 46±14 0.14±0.01 49±11 0.33±0.01 17±3 0.09±0.01 9±3
F203W 0.31±0.02 15±5 0.30±0.02 33±6 0.30±0.01 44±5 0.27±0.02 17±4 0.27±0.01 22±4
PSST parental 0.43±0.03 17±4 0.31±0.01 38±4 0.38±0.03 65±9 0.25±0.02 10±3 0.41±0.03 30±6
V88F n.d. n.d. 0.10±0.02 130±42 n.d. n.d. 0.17±0.01 18±6 n.d. n.d.
M91A n.d. n.d. 0.38±0.10 393±148 n.d. n.d. 0.36±0.02 26±4 n.d. n.d.
M91C n.d. n.d. 0.37±0.06 141±35 n.d. n.d. 0.37±0.02 17±3 n.d. n.d.
a DQA sensitive activities normalized to complex I content (CI) estimated as NADH:hexaammineruthenium oxidoreductase activity [17].
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useful have to be interpreted with caution for hydrophobic substrates
like the short chain ubiquinone derivatives used here: (i) the effective
concentrations in the membranes will be much higher than the ap-
parent KM values that reﬂect the concentration in the total volume
of the assay; (ii) the substrates may form micelles at higher concen-
trations which limits the experimentally accessible range. Therefore,
the markedly increased apparent KM values determined for some of
the mutants should only be considered as crude estimates, as also ev-
ident from the high margins of error associated with these data
(Table 1). Considering that no kinetic parameters could be deter-
mined when the maximal activity was too low, the Vmax values essen-
tially exhibited the same pattern as found with the simple activity
assays shown in Fig. 3A. For mutations M195F, F207W and F203W
there was no signiﬁcant effect on the apparent KM values for all ﬁve
substrates, suggesting that these residues did not directly affect bind-
ing of the substrate to the active site. In contrast, mutation S192I
which showed hardly any activity with the substrates carrying a sat-
urated tail resulted in an about 10fold increased apparent KM for Q1
indicating that this serine residue was critical for productive binding.
Remarkably however, only a slight increase in apparent KM was ob-
served with membranes from this mutant, when Q2 or Q2S was the
substrate, suggesting that the methyl group of the second isoprenoidTable 2
Complex I content and inhibitor sensitive dNADH:ubiquinone oxidoreductase activities
of mutants in the 49-kDa subunita.
dNADH:ubiquinone oxidoreductase activity
Complex I content DBQ Q1 Q1S Q2 Q2S
%
H91Ab 104 b5 b5 b5 10±6 12±2
A94Ic 97 b5 b5 b5 15±12 b5
H95Ab 131 b5 b5 b5 9±2 b5
V97Wc 57 b5 b5 25±6 17±14 b5
L98Fc 107 b5 b5 b5 11±14 b5
R99Tc 72 b5 b5 b5 b5 b5
V145Fc 106 b5 b5 b5 27±10 b5
S146Vd 111 86±12 112±3 105±3 108±9 88±7
M188Yc 91 b5 10±2 b5 b5 b5
M188Ld 106 88±9 73±4 79±4 65±17 84±6
S192Ib 97 b5 28±14 10±2 93±1 20±11
M195F 114 66±12 109±3 82±3 131±9 80±7
F203Wd 126 90±6 153±8 117±5 119±17 102±17
F207Wb 118 41±9 129±7 63±7 166±6 44±5
H226Ae 122 23±9 29±3 23±3 31±16 20±10
V460Ae 121 10±6 24±2 8±1 33±9 b5
a Values are given±SD (n=7–8); Mutants shown in Fig. 3A are underlined.
b Mutant ﬁrst described in [31].
c Mutant ﬁrst described in [17].
d Mutant ﬁrst described in [32].
e Mutant ﬁrst described in [16].unit could compensate for the missing binding interaction to the ﬁrst
isoprenoid unit although changing the stereochemistry of the side-
chain by removing the double bonds in Q2S dramatically reduced
Vmax.3.3. Mutations in the PSST subunit
Since several of the mutations that exhibited ubiquinone tail-
dependent activities reside at the surface of the 49-kDa subunit, we
reanalysed four [17,32,33] and generated 22 additional point muta-
tions in 13 conserved positions of the PSST subunit near the interface
between the two subunits (Table 3). In mitochondrial membranes
from all mutants except M117E and M147E signiﬁcant amounts of as-
sembled complex I were detected by BN-PAGE (Fig. 4). This ﬁnding
was conﬁrmed by measuring NADH:HAR oxidoreductase activities
in all strains (Table 3). It should be noted that introducing a gluta-
mate in all cases resulted in markedly lower enzyme levels suggesting
some destabilisation of the complex by this charged amino acid.Fig. 3. Effects of point mutations in subunits 49-kDa and PSST on catalytic turnover
with ﬁve different ubiquinone derivatives.(A) 49-kDa subunit, (B) PSST subunit. Filled
bars, DBQ; hatched bars, Q1; striped bars, Q1S; open bars, Q2; grey bars, Q2S.
Table 3
Complex I content and inhibitor sensitive dNADH:ubiquinone oxidoreductase activities
of mutants in the PSST subunita.
dNADH:ubiquinone oxidoreductase activity
Complex I content DBQ Q1 Q1S Q2 Q2S
%
W77A 115 28±19 41±2 41±6 52±11 30±3
W77I 69 30±1 38±2 22±2 40±4 21±3
W77E 42 b5 b5 b5 6±2 6±1
F81A 98 b5 7±1 b5 23±7 5±2
F81I 98 11±2 54±6 16±2 82±10 15±1
F81E 34 5±1 b5 b5 12±1 7±1
V88Fb 95 b5 22±3 b5 69±10 b5
M90A 100 5±1 24±1 9±1 16±5 12±2
M90E 65 9±1 44±6 12±2 77±7 10±1
M91A 104 b5 42±1 12±1 136±11 10±4
M91Cc 141 25±7 61±5 28±6 153±13 12±7
M91E 58 9±1 b5 b5 8±2 8±1
M91Kc 77 b5 6±3 b5 b5 b5
M117A 92 b5 7±1 b5 18±5 b5
M117E 17 n.d. n.d. n.d. n.d. n.d.
V119Md 119 53±3 52±2 49±6 72±5 30±7
M127E 68 24±1 74±6 21±3 91±4 18±1
L131M 124 91±8 83±3 94±4 106±12 76±10
Y135A 99 67±12 52±10 57±3 77±7 66±4
Y135I 81 41±1 34±6 27±2 60±8 20±1
M138A 94 52±7 55±9 50±3 65±4 44±8
M138E 53 45±2 73±2 60±2 50±3 41±1
W143A 98 63±7 54±4 51±4 82±7 53±2
W143I 73 17±1 10±4 b5 12±4 7±1
M147A 113 45±8 63±3 43±4 14±6 29±4
M147E 20 n.d. n.d. n.d. n.d. n.d.
a Values are given±SD (n=7-8); Mutants shown in Fig. 3B are underlined.
b Mutant ﬁrst described in [17].
c Mutant ﬁrst described in [32].
d Mutant ﬁrst described in [33].
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F81A, F81E, M91E, M91K, and M117A) resulted in very low inhibitor
sensitive dNADH:ubiquinone oxidoreductase activities with all ﬁveFig. 4. BN-PAGE of mitochondrial membranes.Mitochondrial membranes solubilized in
1.5 g/g β-dodecylmaltoside (135 μg total protein per lane) of the complemented wild
type (Parental) and of the selected mutants of subunit PSST (M117E, M127E, M138E
and M147E) were separated on a 4–16% BN-PAGE gel. In the membranes of mutants
M117E and M147E the content of complex I was markedly reduced. The intensities
of the complex I bands for all other mutants listed in Table 3 were similar to that ob-
served for the complemented deletion strain (not shown). V2, complex V dimer; V,
complex V monomer; I, complex I; III2, complex III dimer.substrates (Table 3). Like for some of the mutations in the 49-kDa
subunit, two of these mutants (F81E and M117A) exhibited some ac-
tivity with Q2. For mutants W77A, V119M, L131M, Y135A, M138A,
W143A, and W143I activities in the range from ~10 to 100% of
wild-type activities were measured that were rather similar for all
ﬁve substrates relative to the parental strain. Notably, also in these
cases the relative rates were somewhat higher for Q2. In contrast,
amino acid exchanges M138E and M147A gave the highest relative
activities with Q1 and Q1S suggesting that a longer side chain was
unfavourable in these cases (Table 3). The quite remarkable substrate
dependent pattern of activities reported above for exchanges S192I
and V460A in the 49-kDa subunit was also found for the PSST-subunit
with mutants F81I, F81A, V88F, M90A, M90E, M91A, M91C and
M127E (Table 3). As illustrated for one of the exchanges at each of
these ﬁve positions (Fig. 3B), saturated side chains gave low activities
in these cases,while activitieswithQ2mostly gave nearwild-type activ-
ities. For M91A and M91C the rates for Q2 were even much higher than
those obtained with the parental strain.
Finally, we determined the Michaelis–Menten parameters for
V88F, M91A and M91C. The same pattern of substrate-dependent ac-
tivity emerged as for mutant S192I in the 49-kDa subunit, except that
for the PSST mutants the activities were too low for all substrates
with a saturated side-chain. While the apparent KM values were
markedly higher for Q1, only a slight increase was found for Q2. This
again suggested that these three mutations directly affected the bind-
ing site for the ﬁrst isoprenoid unit of the ubiquinone side-chain.
3.4. Mutation S192T in the 49-kDa subunit confers hypersensitivity
to rotenone
For Q2, a pronounced substrate inhibition has been reported with
complex I from bovine heart [34] that is not evident in Y. lipolytica.
Thus we checked, whether any of the residues identiﬁed here as
being involved in the interaction with the ﬁrst two isoprenoid resi-
dues of the ubiquinone side-chain, was not conserved between mam-
malian and yeast complex I. Indeed, in the bovine enzyme S192 is
replaced by threonine and M195 by leucine. When we reproduced
these exchanges in Y. lipolytica, overall we observed a slight reduction
in inhibitor sensitive ubiquinone reductase activity for S192T, and a
moderate reduction of the activities with the substrates carrying sat-
urated side-chains for M195L, which closely resembled the pattern
for mutation M195F (Fig. 5A).
Interestingly, we found that complex I frommutant S192Twas about
three times more sensitive to the inhibitor rotenone and the apparent
IC50 value was now similar to that of the bovine heart enzyme
(Fig. 5B). This suggested that this amino acid exchange is speciﬁcally re-
sponsible for the lower afﬁnity of rotenone to complex I from Y. lipolytica
as compared to the mammalian enzyme. In contrast, the apparent IC50
values for DQA, an inhibitor of a different class [17,35], were very similar
with mitochondrial membranes from bovine heart, mutant S192T and
the Y. lipolytica parental strain (Fig. 5C). Mutation M195L resulted in a
slight resistance to both inhibitors.
4. Discussion
Recent insights into the structural organization of complex I by X-
ray crystallography [5,7] indicate that iron–sulfur cluster N2, the im-
mediate electron donor for ubiquinone resides at a position clearly
separated from the membrane domain in the peripheral arm, as had
been suggested previously [36]. Evidence from extensive mutagenesis
studies [17,18] has demonstrated that the active site for the substrate ubi-
quinone is located in close vicinity to cluster N2 near the interface of the
PSST and 49-kDa subunitswithin a rather large binding pocket formed by
the latter (Fig. 1). These ﬁndings are quite remarkable considering that
the physiological substrates ubiquinone-9 and -10 are extremely hydro-
phobic. Since there are also no indications from functional or structural
Fig. 5. Effects of point mutations S192T and M195L in subunit 49-kDa representing the
exchange from Y. lipolytica to B. taurus sequence.(A) Catalytic activities for the different
ubiquinone derivatives in S192 (black bars) and M195L (grey bars). Apparent IC50
values for rotenone (B) and DQA (C) of mitochondrial membranes from the plasmid
complemented Y. lipolytica deletion strain (parental), mutants S192T and M195L and
bovine heart mitochondria (BHM).
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closer to the membrane, it follows that complex I has to provide a
path to allow its hydrophobic substrate to move in and out its active
site in the hydrophilic domain. Taking Y144 in the 49-kDa subunit as
a starting point that seems to bind directly to the head group of ubi-
quinone [18], we searched for residues that interact with the ﬁrst
two isoprenoid units of its tail. To this end we here analysed theFig. 6. Structural model illustrating the positions of the amino acid exchanges.Structures of t
ing cavity of complex I are shown in cartoon representation. All side chains addressed in thi
Y. lipolytica complex I are indicated. H91 in the 49-kDa subunit is not shown, since it is not pr
activity; green and blue, mutant positions in the 49-kDa and PSST subunit, respectively with
ities with all ubiquinone derivatives; dark color indicates higher activities with derivatives c
N6b are shown as orange/yellow spheres; residue Y144 of the 49-kDa subunit marking thefunctional consequences of 42 single amino acid exchanges using
ﬁve short-chain ubiquinone derivatives as substrates that differed
in the structure of their hydrophobic tail (Fig. 2). We reanalysed mu-
tants known to result in signiﬁcant effects on the ubiquinone reduc-
tase activity with DBQ, the standard substrate used in previous
studies, and generated new mutants predominantly in the region of
the PSST-subunit near its interface to the 49-kDa subunit as it ex-
tends towards the membrane domain (Fig. 1).
For the present study it is important to note that short chain ubi-
quinone derivatives can be used to explore the molecular mecha-
nism of complex I, since their reduction by complex I is linked to
proton pumping [18,37] indicating that they are fully functional sub-
strates. The activity of complex I with endogenous Q9 can be assessed
by measuring dNADH oxidase activities of mitochondrial mem-
branes. However, this physiological substrate of Y. lipolytica complex
I is too hydrophobic to be added effectively as substrate in kinetic
assays.
From the obtained large set of data (Tables 2 and 3) we obtained
useful insights on the structure/activity relationships around the
ubiquinone active site of complex I. In addition to the previously
identiﬁed region within the 49-kDa subunit (Fig. 6, green side
chains; [17]), also in the PSST subunit the exchange of a set of resi-
dues lining the interface between the two subunits resulted in low
or very low ubiquinone reductase activities (Fig. 6, blue side chains).
Mutagenesis exchanging residues positioned more deeply in the
subunits had less pronounced or no effect on activity (Fig. 6, grey
side chains). While the 49-kDa subunit seems to harbour a rather hy-
drophilic pocket that opens to thewater phase near the phospholipid
head group region [17], the critical residues identiﬁed here especial-
ly in the PSST subunit carry hydrophobic side chains. This suggests
that access and binding of the rather hydrophilic head group of ubi-
quinone occurs through the 49-kDa subunit, while the hydrophobic
side chain slides along the surface of the PSST subunit facing the
49-kDa subunit into position for catalysis.
The most distant of the residues on this end wereW77 andW143
that reside near so called Helix 1 which sticks out horizontally at the
side of the peripheral arm of complex I at about 10 Å above mem-
brane level (Fig. 1). Their distance from the hydroxyl group of
Y144 that has been proposed to form a hydrogen bond to the headhe 49-kDa (green), PSST (blue) and TYKY (beige) subunits around the ubiquinone bind-
s study are shown in stick representation and their position in the respective subunit of
esent in the 2FUG coordinates. Grey, mutant positions with moderate effect on catalytic
signiﬁcant effects on activity (see Tables 2 and 3). Light color indicates reduced activ-
arrying an isoprenoid as compared to a saturated side chain. Iron–sulfur cluster N2 and
binding site of the ubiquinone head group is shown as red sticks.
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the total length of the short chain ubiquinones used here is only
about 15 Å the changes in activity caused by exchanging these
large aromatic side chains with alanine or isoleucine must have
been due to indirect effects, but still are in line with the idea that
this part of the PSST subunit is involved in the access of ubiquinone
to its site.
The structure/activity relationships found following exchanges of
eight other residues were much more informative. Exchanging six of
these residues, S192 and F207 in the 49-kDa subunit and F81, M90,
M91 andM127 in the PSST-subunit, resulted in very low or markedly
reduced activities with all three ubiquinone derivatives carrying sat-
urated side chains. Remarkably however, much higher activities
were observed with isoprenoid tails, reaching or even surpassing
wild-type levels for Q2 (Fig. 3). This indicated that these residues
are important for the interaction of the ubiquinone tail with the ac-
tive site of complex I and since all of these six residues are found at
a distance of about 10–14 Å from the hydroxyl group of Y144, it
seems likely that they are involved in the access and binding of the
hydrophobic parts of ubiquinone (Fig. 6). To some extent, the same
pattern was observed with M195 and for Q1 also with F203 of the
49-kDa subunit that reside somewhat further away at a distance of
about 16 Å.
Interestingly, four of the residues of which an exchange had ef-
fects that depended distinctly on the structure of the ubiquinone
tail were methionines. Clusters of methionines were previously de-
scribed as so called M-domains in the signal recognition particle,
where their long and ﬂexible side chains were proposed to act like
“bristles” along which the hydrophobic targeting sequences pass to
reach their binding site [38]. It was shown that the chemical proper-
ties of the methionine side chain are ideal to provide a low energy
barrier path for hydrophobic molecules within a protein [39]. It
thus seems plausible that the rim of methionines and their neigh-
bouring amino acids at the interface between the 49-kDa and the
PSST subunits forms a kind of hydrophobic gate for the ubiquinone
tail to the binding pocket. The different effects of exchanging the
residues in this region on the catalytic activities with the different
short chain ubiquinone derivatives reported here could then be
explained by assuming that they form something like a bottleneck
for the ubiquinone tail on its path into the site. The position of the
gate at about 10–15 Å away from Y144, the residue that presum-
ably forms a hydrogen bond with one of the head group carbonyls
[17], would suggest that the binding of ubiquinone to its active
site engages also the ﬁrst two isoprenoid groups of its tail. This
ﬁts nicely to the observation that Q2 exhibits product inhibition
with bovine heart complex I [34]. Notably, S192 that is positioned
towards the previously deﬁned binding pocket for the head group
(Fig. 6, [18]) is exchanged to threonine in bovine complex I and
we could show that this exchange is responsible for the higher
efﬁciency of the inhibitor rotenone in this organism (Fig. 5).
Exchanges of V460 and V88, which are located much closer to
Y144, resulted in the same pronounced structure/activity pattern
(Fig. 3). We propose that, as with exchanges of Y144 itself, chang-
ing the environment of the binding pocket around the head group
in these cases indirectly affected the steric requirements for the
tail passing through its gate.Acknowledgements
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